Assenagon Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
212,342
-90,557
| -30% | -$101K | ﹤0.01% | 1080 |
|
|
2025
Q1 | $239K | Sell |
302,899
-69,608
| -19% | -$55K | ﹤0.01% | 1075 |
|
|
2024
Q4 | $615K | Sell |
372,507
-2,061,691
| -85% | -$3.4M | ﹤0.01% | 1150 |
|
|
2024
Q3 | $8.52M | Sell |
2,434,198
-140,505
| -5% | -$492K | 0.02% | 552 |
|
|
2024
Q2 | $8.45M | Buy |
2,574,703
+26,399
| +1% | +$86.6K | 0.02% | 454 |
|
|
2024
Q1 | $18.7M | Buy |
2,548,304
+2,385,207
| +1,462% | +$17.5M | 0.04% | 275 |
|
|
2023
Q4 | $610K | Sell |
163,097
-217,640
| -57% | -$814K | ﹤0.01% | 1174 |
|
|
2023
Q3 | $807K | Buy |
380,737
+280,895
| +281% | +$595K | ﹤0.01% | 1066 |
|
|
2023
Q2 | $475K | Buy |
+99,842
| New | +$475K | ﹤0.01% | 1097 |
|
|
2022
Q4 | – | Sell |
-14,583
| Closed | -$327K | – | 1333 |
|
|
2022
Q3 | $327K | Sell |
14,583
-21
| -0.1% | -$471 | ﹤0.01% | 1137 |
|
|
2022
Q2 | $362K | Sell |
14,604
-6
| -0% | -$149 | ﹤0.01% | 1243 |
|
|
2022
Q1 | $566K | Sell |
14,610
-5
| -0% | -$194 | ﹤0.01% | 1133 |
|
|
2021
Q4 | $855K | Sell |
14,615
-109,893
| -88% | -$6.43M | ﹤0.01% | 1033 |
|
|
2021
Q3 | $7.38M | Sell |
124,508
-292,850
| -70% | -$17.4M | 0.02% | 299 |
|
|
2021
Q2 | $36.2M | Buy |
+417,358
| New | +$36.2M | 0.12% | 122 |
|
|
2021
Q1 | – | Sell |
-25,323
| Closed | -$2.3M | – | 1188 |
|
|
2020
Q4 | $2.3M | Sell |
25,323
-57,776
| -70% | -$5.25M | 0.01% | 459 |
|
|
2020
Q3 | $3.32M | Buy |
83,099
+42,721
| +106% | +$1.71M | 0.02% | 434 |
|
|
2020
Q2 | $1.39M | Buy |
+40,378
| New | +$1.39M | 0.01% | 682 |
|